Abstract Coronary vascular endothelial cells release substances into the coronary circulation that modify the contractile system of cardiac myocytes, and cardiac myocytes may release factors that modulate the secretion of cardioregulatory substances by endothelial cells. This regulatory loop is sensitive to the rate of coronary flow and tissue oxygen tension. In the present study, coronary venous effluent from isolated perfused hearts and the contents of the coronary vascular endothelial cells have been collected, the latter by disrupting the cells with coronary perfusion at high pressure. The relative amounts of upregulating and downregulating factors in both collections have been estimated by assaying their effects on the contractility of isolated cardiac trabeculas. The amount of upregulating factor stored in the endothelial cells is sensitive to the rate of coronary flow just before disruption of the cells. The quantity of endothelin in the coronary venous effluent and in the vascular endothelial cell contents was measured by radioimmunoassay and compared with the degree of upregulation of contractility produced by the two types of solutions. Upregulation was never produced in the absence of endothelin. The extent of the increase in contractility that was observed with endothelial cell contents correlated with the concentration of endothelin and was approximately the same as the increase in contractility from similar concentrations of endothelin added to standard Krebs' solution. The amount of the increase in contractility from coronary effluent could be accounted for by the concentration of endothelin in the effluent with the additional presence of some downregulating factor as well. The endothelin antagonist BQ123 inhibited the upregulation from coronary perfusate. It appears that endothelin alone can account for all of the upregulation of contractility produced by the vascular endothelial cells. Coronary flow, probably through shear forces, seems to regulate the production of endothelin possibly from an inactive precursor.
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Tissue oxygen tension appears to modulate the rate of release of the endothelin from endothelial cells though substances released by cardiac myocytes or other cells in the tissue. The downregulating factor is stored to a much smaller extent. (Circ In the past few years, different lines of investigation of cardiac muscle have begun to converge on a mechanism that allows this organ, under normal conditions, to meet the needs of the organism without compromising its own viability. Endothelial cells of both the endocardium and the coronary blood vessels can exercise substantial control over the contractility of cardiac myocytes.1-3 The myocytes, in turn, are able to modulate the function of the endothelial cells. 2 The endothelial cells are sensitive to the shear stress produced by the flowing blood, and the myocytes appear to act as sensors of oxygen tension. This interaction between endothelial cells and contractile cells occurs through the release of molecular signals and contributes to the coordination of the contractile performance of the myocyte with its available energy supply. 2 The original studies of endothelial cell regulation of contractility focused on vascular smooth muscle as the target tissue4 and demonstrated that the endothelial cells acted as an intermediary for neurotransmitters and humoral agents in their control of smooth muscle tone.
Substances like acetylcholine and bradykinin caused the endothelial cells to release molecules that modified the tone of smooth muscle. Among the several active substances released by the endothelial cells, two have received specific attention: nitric oxide and endothelin.56 Nitric oxide, a very labile substance synthesized from arginine, activates guanylyl cyclase to raise the concentration of cGMP in the target cell. 5 In smooth muscle cells, the elevation of cGMP produces relaxation. Endothelin is a relatively stable peptide that is produced by proteolysis of a precursor and causes contraction of smooth muscle, presumably by enhancing the phosphorylation of the regulatory light chain of myosin. 6 Cardiac muscle cells are also regulated by endothelial cells. In isolated cardiac tissue, removal of the endocardial endothelium produces a decrease in the peak force and the time to peak force during a contraction.1 Although these changes can be reversed by bathing the tissue with a medium previously conditioned by cultured aortic endothelial cells, the identity of the active substance is not yet known. 7 Endothelin, which has been shown to exert a positive inotropic effect on isolated cardiac muscle by modifying the properties of calcium channels and by changing the response of the contractile proteins to given concentrations of calcium ions,8-10 may be involved. Nitric oxide produced by the cardiac myocytes themselves can modify contractility by inhibiting the positive inotropic response to 13-adrenergic Although it has been shown that the rate of coronary flow and the tissue oxygen tension are important parameters in modulating the endothelium-derived cardioregulatory mechanism, the specific sites at which these influences are exerted have not been identified. Some data have supported the notion that shear stress on the endothelial cells modifies the expression of genes, in particular, the ones encoding the endothelins.1243 However, the speed of response of the cardiac cells to disruption of endothelial cells and to change in coronary flow strongly suggests that posttranslational changes modifying contractility are important components of the endothelial response to physical and/or chemical changes in the environment.
The identity of the cardioregulatory material produced by the endothelial cells and the conditions controlling their release are of prime importance. To understand the modulation of the endothelium-derived cardioregulatory mechanisms, it is important to determine how endothelial cell content, the rate of coronary flow, and the level of tissue oxygen tension influence the amount of cardioregulatory material secreted into the coronary fluid. These data could reveal which steps in the process of synthesis and release of the cardioregulatory factors are sensitive to shear stress and oxygenation. A necessary step in the execution of this project was the development and validation of the technique for selectively collecting and assaying the intracellular contents of coronary vascular endothelial cells. To accomplish this, the technique of Ramaciotti et a12 was modified to allow the collection of the diffusible contents of disrupted coronary endothelium without using substances that could interfere with the assay.
The results indicate that endothelin is the endothelium-derived upregulating factor. Its conversion from inactive precursor to active substance may be controlled by coronary flow, presumably through shear stress on the endothelial cells. Tissue oxygen tension, apparently operating through substances released by the other cells in the heart, possibly cardiac myocytes, influences the rate of its secretion.
Materials and Methods
In the present study, the coronary venous effluent from an isolated perfused working heart was collected and assayed for effects on contractility by using it, after reoxygenation, as the bathing medium for trabeculas isolated from another heart. This procedure has already been described in detail. begun with a constant pressure of 70 cm H20 to maintain the heart before the establishment of the working heart preparation. After the insertion of a cannula into the pulmonary artery and a second cannula into the left atrium via the left atrial appendage, the retrograde perfusion was terminated, and the working heart was established with a left atrial pressure of 10 cm H20. The aortic flow and pressure and the pulmonary flow and oxygen saturation of the pulmonary effluent were all monitored continuously on a strip-chart recorder. These values were sampled every 12 seconds, digitized, and stored on a computer disk for later analysis. Two right ventricular trabeculas were isolated from a second heart and mounted in Krebs' solution to serve as assay tissues for the contractile effect of coronary venous effluent collected from the perfused heart.
After the hemodynamic and metabolic performance of the isolated perfused hearts had stabilized over 40 to 60 minutes, a sample of the coronary venous effluent was collected during a 3-to 5-minute period and briefly applied to the trabeculas to determine the effect on contractility. Fifteen minutes later, standard Krebs' solution replaced the effluent as the bathing medium for the trabeculas.
The working heart was then switched back to a Langendorff mode with constant flow. The perfusion pump was set to deliver approximately the same rate of coronary flow (100% to 125%) that existed in the stable working heart. The heart was allowed to equilibrate for 5 minutes, and then the flow was increased to raise the perfusion pressure. The initial step was a doubling of the flow, which commonly resulted in an increase in pressure to > 150 mm Hg and was followed by further small increments to increase the pressure to =200 mm Hg. The elevated rate of flow was maintained for 10 minutes and then restored to the original rate. As the coronary flow was reduced after the period of high pressure, perfusion pressure fell, but even when flow had returned to its initial level, perfusion pressure remained significantly above its initial level. Three to 5 minutes later, the heart was returned to the working mode by raising the left atrial pressure to 10 cm H20 and terminating the retrograde flow. The total time in the Langendorff mode was -20 minutes. Coronary effluent was collected during the 10 minutes of perfusion at high pressure. It was reoxygenated and then briefly substituted for the normal bathing medium of isolated trabeculas to determine its effect on their contractility. This protocol is shown in Table 1 .
At various times after the isolated heart had been restored to the working mode after the period of high-pressure perfusion, the coronary venous effluent was collected for -10 minutes and assayed for cardioregulatory activity on the same trabeculas. In several experiments, multiple periods of collection of coronary effluent and multiple assays for cardioregulatory effects were carried out.
Each collection of coronary effluent was assayed on trabeculas in which endocardial endothelial cells had been disrupted by a 1-second exposure to 0.5% Triton X-100.1 This assay detects only endothelium-derived factors.
Aliquots of perfusate were taken before and during the initial part of the high-pressure perfusion. The total protein in the perfusate was measured by use of the procedure of Ohnishi and Barr as distributed in Sigma procedure No. 690 (Sigma Chemical Co). The color was allowed to develop for 30 minutes at room temperature (21°C), and then it was read at a wavelength of 725 ltm. Bovine serum albumin from Sigma was used as the standard. The sensitivity of this procedure was 1 ,ug/mL. Aliquots were also electrophoresed on polyacrylamide gels and silver-stained. (2) The ultrastructure of the cardiac myocytes had to be completely normal except for dilation of the transverse tubular system, a phenomenon that generally occurs in isolated perfused hearts. The sarcolemma had to be intact, and the myofibrils had to have retained their normal filament organization. (3) The ultrastructure of the vascular smooth muscle cells had to be intact. (4) After the disruption of the endothelial cells, there should be no change in coronary vascular resistance in response to methacholine, which alters coronary resistance through the intermediary of the endothelial cells. The method selected for disruption was perfusion of the coronary circulation with a normal electrolyte solution at an elevated pressure. This approach was chosen in preference to perfusion with detergent or air because it produces selective disruption without introducing substances that interfere with the assay and because it permits the collection of the contents of the cells during the period of coronary perfusion at high pressure. After reoxygenation of the high-pressure effluent, an aliquot was removed and used as the bathing medium for trabeculas that had been isolated from another heart. After the period of high-pressure perfusion in the Langendorff mode, the heart was restored to the working heart mode, and coronary venous effluent was collected 30, 60 and 90 minutes later for assay to determine whether regulatory factors released from the endothelial cells had remained bound within the heart. Eight hearts perfused with standard Krebs' solution in a Langendorif mode at a perfusion pressure between 180 and 200 mm Hg were fixed by perfusion with glutaraldehyde, and their left ventricles were sectioned. Several sections were taken from different depths through the ventricular wall of each heart, and the ultrastructure was examined. No endothelial cells with intact membranes were seen in the arterial microvasculature in any portion of any section of the eight hearts (Fig 1) . Most vessels. This result showed that endothelial cells are intact in the hearts during normal perfusion. In 5 of these hearts, the response to methacholine was tested after the exposure of the heart to high-pressure perfusion and return to normal perfusion in the working heart mode. No significant change in coronary flow (2+4%) occurred under these conditions, showing that the high-pressure perfusion removed the endothelial cells.
After the period of high-pressure perfusion and restoration to the working mode, some changes in hemodynamic performance of the hearts were observed. Mean aortic pressure, which was controlled by a combination of the height of the outflow tract and the series resistance, did not change significantly. The In a majority of the experiments, exposure to the coronary effluent changed the force of contraction, most often by increasing developed tension (Fig 3) . The total cardioregulatory activity released by the cells during disruption was estimated from the product of the relative change in contractility and the total volume of coronary effluent collected during and after the period of disruption of the endothelial cells.
Relation to Coronary Flow
The direction and amplitude of the change in contractility produced by endothelial cell contents collected during the high-pressure perfusion were related to the rate of coronary flow that existed in the isolated working heart just before the disruption of the vascular endothelial cells (Fig 4) . At low levels of coronary flow, the endothelial cell contents caused no significant change in the peak force developed by the trabeculas. Peak 
Relation to Oxygen Tension
Reoxygenated coronary effluent that was collected before disruption of the vascular endothelial cells changed the contractility of the trabeculas. Both the amplitude and direction of change were related to the oxygen tension that was present in the effluent before it was reoxygenated (Fig 5) . This has already been described.2 However, the degree of oxygen saturation of the coronary effluent at the time of the changeover from the working heart mode to the high-pressure perfusion in preparation for disruption of the vascular endothelium had no apparent influence on the amounts of cardiac-regulating substances in the vascular endothelium (Fig 6) . This is not surprising inasmuch as the oxygen tension in the microenvironment of the arterial vascular endothelium, which is the source of the cardioregulatory factors,2 would have been close to saturation regardless of the oxygen tension in the vicinity of the myocytes and the venous microvasculature.
Relation Between Storage and Release of Endothelial Cardioregulatory Factors
It was of interest to determine whether the rate of release of cardioregulatory factors was simply related to the amount that was stored in the endothelial cells. This would expected if regulation of the rate of release occurred primarily by the rate of synthesis of the factors. For this reason, the relation between the amount of cardioregulatory factors stored in the endothelial cells and the rate of release of cardioregulatory factors was examined. The comparison would also indicate whether the endothelial cells in an isolated perfused heart were able to maintain their stores of cardioregulatory factors or whether depletion of the stores contributed to the decline in function of isolated working hearts that generally occurs after =4 hours. The ability of the vascular endothelium to maintain the cell store of upregulating factor was examined by comparing the apparent rate of release of upregulating factor over 90 to 120 minutes with the amount stored in the endothelial cells at the end of this period. The population of hearts studied was divided on the basis of coronary flow into two groups, those with low coronary flow (<10 mL/min) and those with high coronary flow (>10 mL/min) at the time of disruption of endothelial cells, because the data reported above suggested that at relatively low rates of coronary flow, endothelial cells did not store the active form of upregulating factor (see "Discussion"). In the low coronary flow group of seven hearts, there was no storage of upregulating factor and no upregulation by the coronary perfusates collected before endothelial cell disruption. In contrast, for the group of hearts with high coronary flows and endothelial cells containing upregulating factor, an inverse relation existed between the relative concentration of upregulating factor in the high-pressure perfusate and the change in contractility produced by coronary effluent from the same heart before disruption of the (Fig 9) . To allow for full response to the perfusate or endothelin, readings were taken 15 minutes after addition of the material. coronary endothelium (Fig 7) . The nature of the relation was unchanged when the total amount of upregulating factor collected from the endothelial cells (ie, relative concentration times volume of perfusate) was compared instead of relative concentration (data not shown). These data indicate that the greater the rate of release of upregulating factor from intact endothelial cells, the smaller the store of upregulating factor in the endothelial cells at the time of disruption. Apparently, synthesis of this cardioregulatory substance does not keep up with release. This phenomenon probably accounts for the absence of upregulating factor in the contents of endothelial cells in the one experiment in which the factor had been released into the effluent earlier in the experiment. The size of the store of upregulating factor does not appear to have a primary role in controlling the rate of release by the endothelial cell.
Of the hearts in which coronary flow was >10 mL/ min, the contents of the endothelial cells in all but two produced upregulation (Fig 7) . On the other hand, coronary venous effluent collected before endothelial cell disruption sometimes produced downregulation even when the contents of the endothelial cells produced upregulation. This result showed that downregulation could be produced by coronary perfusate even when the endothelial cells did not contain a preponderance of downregulating material. Since downregulation has been shown to disappear when vascular endothelial cells are damaged, the source of the factor is unlikely to be another cell. Either endothelial cells do not store downregulating factor, or they store less of it than upregulating factor even when they are releasing the downregulating factor.
Concentration of Endothelin in the Endothelial Cell Contents and Coronary Venous Effluent
The concentration of endothelin in the endothelial cell contents was measured and compared with the change in the contractility produced in isolated trabeculas (Fig 8) . The correlation between the endothelial cell content of endothelin and the effect on contractility was very good. In all seven experiments in which no endothelin was detected, the endothelial cell contents caused no change in contractility (the assay will detect <0.1 pmol/L endothelin). In the rest of the experiments, there was a very good correlation between the extent of increase in contractility and the concentration of endothelin (correlation coefficient, 0.73).
A dose-response curve relating increase in contractility of isolated trabeculas to the concentration of endothelin-1 added to the Krebs' solution bathing the trabeculas was generated to compare the effects of endothelin in the endothelial cell contents with endothelin added to standard Krebs' solution (Fig 9) . In generating the curve, great care was taken to have trabeculas in the same condition as in the assay of the endothelial cell contents. The tissues were bathed with Krebs' solution until the contractility of the trabeculas had stabilized, and the endocardial endothelium was disrupted by 0.5% Triton X-100 to minimize background production of endothelin by the trabeculas. This attention is crucial because the sensitivity to endothelin added to the bathing solution is reduced substantially by the presence of endothelial cells secreting endothelin in the tissue.910'617 The dose-response curve was very similar to that observed by Kelly et al. 16 The threshold for a response was =-1.0 pmol/L, 50% of the maximum effect was achieved with 25 to 50 pmol/L, and peak effect was an increase of 70% to 80% of basal value. When the effect on contractility of endothelin in Krebs' solution was compared with the effect of endothelin in the endothelial cell contents, the two relations were very similar. Endothelin alone could account for all the upregulating activity in the endothelial cell contents.
The relation between the change in contractility and the amount of endothelin in the coronary venous effluent collected before disruption of endothelial cells was more complex. Although most of the points fell along the endothelin dose-response relation, several samples of perfusate produced either no increase or a decrease in contractility, even though endothelin was present in the perfusate. There was no significant linear correlation between the amount of endothelin in the perfusate and the effect on contractility (Fig 10) . A deviation from a linear correlation could be explained by the presence of an endothelium-derived downregulating factor in the perfusate that is not stored in high concentration in the endothelial cells, as suggested above and by Ramaciotti et al. 2 When endothelin was absent from the coronary effluent, no endothelin was found in the contents of the coronary endothelial cells.
To test the explanation that endothelin in the perfusate was responsible for the upregulatory activity and (Fig 9) . each experiment, two trabeculas from the same heart were used. One of the trabeculas was exposed to endothelin inhibitor BQ1 23 and the other to BQ1 23 in perfusate. Use of a trabecula from the same heart as a control has already been shown to be valid.2 The data refer to percentage change from the baseline force development in the absence of perfusate or BQ123.
that the presence of downregulating factor in different concentrations was responsible for the complexity of the effect of the perfusate, BQ123, a competitive inhibitor of endothelin,18 was added to the perfusate. The effect of BQ123 was examined by comparing the changes in contractility produced by the effluent with and without BQ123 on two different trabeculas taken from the same heart. In this way, residual effects of endothelin, which are known to reverse very slowly, would be avoided. Previous work2 has shown that trabeculas from the same heart are valid controls and show no significant difference in the responses to endothelium-derived cardioactive factors. Addition of 0.8 ,umol/L BQ123 to coronary venous effluent containing upregulating factor completely blocked the increase in contractility of the assay E, trabeculas (Fig 11, Table 2 ). The same concentration of BQ123 had no effect on the contractility of wellstabilized isolated trabeculas bathed in standard Krebs' solution. Conversion of an increase to a decrease in contractility by the addition of BQ123 was sometimes seen and indicates that endothelin and downregulating factor are present together in the coronary perfusate. From the concentration of endothelin in the effluent, the volume of the recirculating perfusion medium (100 mL), and the time of perfusion (60 to 90 minutes), an estimate of the rate of secretion of endothelin can be calculated. For hearts of -1 g, the rate of secretion under the conditions of the experiment was~"0.005 to 0.02 pmol/min. The amount of endothelin stored in the endothelial cells was between 0.1 and 0.4 pmol. If the coronary vascular endothelium is =1% of the volume of the heart, the concentration of endothelin in the endothelial cells would be 10 nmol/L if it is uniformly distributed. If it is concentrated in vesicles, it may be much higher. After 90 to 120 minutes of perfusion, the endothelial cells in the coronary vessels in an isolated perfused heart contain a 10-to 30-minute supply of endothelin.
There was a close relation between the changes in the coronary vascular resistance after endothelial cell disruption and the changes in contractility of trabeculas produced by the endothelial cell contents. Over most of the range of values, the relative changes in vascular resistance and contractility of the trabeculas were proportional, and at the highest values for change in cardiac contractility, the values for change in coronary resistance appeared to approach saturation (Fig 12) . Endothelial contents released into the coronary perfusate appeared to increase the contractility of isolated cardiac trabeculas to the same degree that they increased the tone of vascular smooth muscle. There was no increase in the contractility of the perfused heart from release of endothelial cell contents commensurate with the increase in the assay trabeculas, but this was probably the result of the increase in coronary resistance after disruption of the endothelial cells and the subsequent decline in coronary flow and coronary venous oxygen tension. A low supply of oxygen to cardiac myocytes can prevent the increase in contractility from inotropic agents. The high-pressure technique for disrupting vascular endothelium leaves essentially all of the venous endothelium and a minor fraction of the capillary endothelium intact, as determined by ultrastructure. This residual vascular endothelium does not interfere with the interpretation of the changes in contractility produced by the coronary venous effluent; a previously published work by Ramaciotti et a12 has shown that the presence of cardioactive factors in the coronary venous effluent is completely inhibited by the disruption of vascular endothelial cells in the arterial side of the coronary vasculature. Although venous endothelium and endocardial endothelium are able to produce and release endothelin, these endothelial cells do not appear to participate in the release of cardioactive substances in the isolated perfused working heart. These results do not preclude a role for venous endothelium in the production of endothelin under different conditions. However, in view of the fact that endothelin produced by the coronary venous endothelium would have been diluted in the systemic circulation and exposed to the lungs before it reached the cardiac myocytes, endothelin derived from venous endothelial cells is less likely to play a important role in regulating cardiac myocytes.
Identity of the Upregulating Factor
Endothelin was present in all aliquots of coronary venous effluent that produced an increase in contractility, including those containing coronary endothelial cell contents. When endothelin was undetectable, an increase in contractility was never produced. The change in contractility produced in the presence of a given concentration of endothelin in coronary effluent was sufficient to account fully for upregulatory effects of endothelium-derived substances. Further support for these conclusions comes from the ability of BQ123, a competitive inhibitor of the endothelin A receptor, to block the upregulating effect.
From the calculated amount of endothelin present in the coronary vascular endothelium and the estimated rate of secretion after 90 to 120 minutes of coronary perfusion in an isolated perfused heart, one would estimate that the endothelial cells contain up to 30-minute stores of the peptide. Since it appears that the rate of synthesis lags substantially behind the rate of secretion in the isolated heart, one would predict that after an additional period of perfusion, possibly something like 60 minutes, the ability of the endothelium to upregulate the cardiac myocytes would begin to decrease significantly and that a deficiency of endothelin could contribute to the decline in both the contractility and the adaptability of the heart that has been observed to occur after this period. The extent to which endothelin deficiency contributes to the decline in function remains to be evaluated.
If endothelin had been released into the coronary perfusate during the period of high-pressure perfusion, one would have expected to see a change in the performance of the perfused heart that was related to the change in contractility produced in the trabeculas by the coronary perfusate. No change in the contractility of the perfused heart was observed. However, in most of the experiments there was a close relation between the increase in coronary resistance, presumably from contraction of vascular smooth muscle, and the increase in The rate of flow of electrolyte solution through the coronary vessels in isolated perfused working hearts is much higher than that which normally exists for the blood flow in the in situ heart. Because of the much lower viscosity of Krebs' solution, the shear stress is much less than that of blood flowing through the same vessels at the same rate. The rate of blood flow that would produce the same shear force as an electrolyte solution is roughly two thirds less.22 Therefore, the level of blood flow in the coronary vessels of the intact rat at which the endothelial cells begin to store endothelin is -3 mL/min or just a bit above the value in the resting animal. This would suggest that endothelium-derived upregulation of the contractility of the myocytes begins when the animal begins to engage in a significant level of activity. The rate of formation of endothelin may be substantially lower in the isolated heart than in the in situ heart and account for the somewhat limited range of coronary flows over which upregulation is seen.
Influence of Oxygen Tension
The relative amount of upregulation or downregulation of contractility produced by vascular endothelial cells is related to the tissue oxygen tension.2 This relation disappears when the endothelial cells in the assay trabeculas have been damaged but not if the endothelial cells in the perfused heart are disrupted. Preendothelial factors produced by the cells remaining after the high-pressure perfusion appear to be responsible for the oxygen sensitivity. These cells could be the cardiac myocytes or remaining venous endothelium, making either possible "oxygen sensors" in the endothelial cell-myocyte loop. Since the relative amount of cardioregulatory factors stored in the endothelial cells in active form is independent of tissue oxygen levels, the rates of synthesis of the cardioregulatory factors and their conversion to active forms do not appear to be modulated by the preendothelial factors. It is likely that the oxygen-sensitive preendothelial factors influence the rate of secretion of endothelin. Possible candidates for this preendothelial function are ATP and adenosine released by cardiac myocytes. (These are currently under study.) Both are known to modulate coronary vascular endothelial cell function. The presence of the oxygen sensor in the myocyte would provide an effective means for the endothelium-based regulatory mechanism to reflect the net oxygen supplied to and used by the myocytes. Venous endothelial cells might function in a similar way. The arterial endothelial cells themselves normally see only fully oxygenated blood.
Although it is clear that the endothelial cells release a downregulatory as well as an upregulatory factor,1"23 the downregulatory substance, which can be detected in the coronary venous effluent even in the presence of endothelin, is probably not stored to the same extent as endothelin, since it cannot be detected in the endothelial cell contents. The molecule may be simpler, more easily synthesized, or stored primarily in an inactive form. It is also possible that the downregulating factor is degraded by something in the cell contents released during endothelial cell disruption and that normally the factor is sequestered in the cell away from the degrading substance.
In summary, these data indicate that endothelin is the endothelium-derived upregulatory factor. They suggest that there may be at least three different control sites in the production and release of endothelin: (1) synthesis of a precursor, presumably regulated at the level of the gene; (2) conversion of the precursor to an active form, a step apparently sensitive to the rate of coronary flow; and (3) the rate of secretion of the active form, a step sensitive to substances released by cardiac myocytes or other cells in the tissue in response to oxygen tension in their local environment. Synthesis of endothelin in the isolated working heart perfused with a standard Krebs' solution probably does not keep up with its rate of release, leading to intracellular depletion among endothelial cells. This imbalance between rates of synthesis and secretion may contribute to the decline in function of the isolated heart as the match between energy supply and work through autoregulation is progressively impaired. The downregulating factor has not been identified as yet, but it does not appear to be stored in large amounts. It is produced as needed.
